The 21st Century Cures Act, which was years in the making, passed the Senate in a 94-5 vote after it was overwhelmingly approved by the House last week.
The complex healthcare legislation would increase funding for medical research, enhance mental healthcare research, provide more money to fight the nationwide opioid epidemic and significantly change the regulatory system for medical devices and drugs.
Much of the criticism of the bill centers on provisions that will enable faster approval of prescription drugs and medical devices. Although supporters say the new measures will preserve safety standards, opponents — including Sen. Warren, some former FDA officials and national consumer groups — disagree. In late November, Sen. Warren accused Republican legislators of trying to extort Democrats by tying additional funds for medical research to the bill. “I cannot vote for this bill,” she said on the Senate floor, according to STAT. “I will fight it because I know the difference between compromise and extortion.”
However, President Obama said he will sign the bill. “This is a reminder of what we can do when we look out for one another,” said President Obama. “Like Joe Biden and so many other Americans, I’ve lost people I love deeply to cancer. I’ve heard often from those whose loved ones are suffering from Alzheimer’s, addiction and other debilitating diseases. Their heartbreak is real, and so we have a responsibility to respond with real solutions. This bill will make a big difference, and I look forward to signing it as soon as it reaches my desk.”
For more information on the 21st Century Cures Act, read the full New York Times report here.
More articles on legal and regulatory issues:
OIG expands Anti-Kickback Statute safe harbors: 6 things to know
7 latest lawsuits involving hospitals
Police arrest armed man outside Illinois hospital
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
